Clinical Trials | April 05, 2022
SRL Diagnostics and Skye Air Mobility join hands to use drones for collection
Drones will be used in the Gurugram and Mumbai region to transport pathology samples
Drones will be used in the Gurugram and Mumbai region to transport pathology samples
Announces pilot project for rapid, remote diagnosis of tuberculosis
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Sanofi’s DE&I Board will include three of the most influential voices in the DE&I space as Board members appointed for 3 years: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer and renowned thought-leader Dr. Rohini Anand
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India
Subscribe To Our Newsletter & Stay Updated
